Shkreli resign as head of Turing taking after capture

Martin Shkreli has surrendered as CEO of Turing Pharmaceuticals taking after his capture, the organization has said.

Ron Tilles will assume control from Mr Shkreli, who has been blamed for securities extortion in connection to a medication organization and a fence stock investments he oversaw.

Turing and Mr Shkreli got to be scandalous in the US for raising the cost of a HIV drug by 5,000% prior this year.